Publications by authors named "Ke Hong Bi"

Claim this Profile
T
The Eastern Cooperative Oncology Group Score Rather Than Donor Type Impacts Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients Aged 51-60 Years: A Retrospective Study From the Chinese Blood and Marrow Transplant Registry.
Xin Zhao, Ming Zhou, Bao-Dong Ye, Er-Lie Jiang, Dai-Hong Liu, Ke-Hong Bi

Clin Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes between haploidentical and matched related donors for chronic myelomonocytic leukemia: A multicenter real-world study.
Yu-Qian Sun, Li-Xin Wu, Yi-Cheng Zhang, Ya-Jing Xu, Xiao-Bing Huang, Li-Bing Wang, Ke-Hong Bi, Zhi-Lei Bian

Int J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multifactorial risk scoring system for the prediction of early relapse in CMML patients with allo-HSCT: a nationwide representative multicenter study.
Jian-Ying Zhou, Yu-Xiu Chen, Hai-Long Yuan, Ya-Jing Xu, Xiao-Bing Huang, Ke-Hong Bi

Bone Marrow Transplant· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a novel prognostic model on allogeneic hematopoietic stem cell transplantation outcomes in patients with CMML.
Jian-Ying Zhou, Song Wang, Hai-Long Yuan, Ya-Jing Xu, Xiao-Bing Huang, Li-Bing Wang, Ke-Hong Bi, Zhi-Lei Bian

Am J Hematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Retracted] and anticancer effects of marmesin in U937 human leukemia cells are mediated via mitochondrial‑mediated apoptosis, cell cycle arrest, and inhibition of cancer cell migration.
Lin Dong, Wen-Wei Xu, Hong Li, Ke-Hong Bi

Oncol Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo anticancer effects of marmesin in U937 human leukemia cells are mediated via mitochondrial-mediated apoptosis, cell cycle arrest, and inhibition of cancer cell migration.
Lin Dong, Wen-Wei Xu, Hong Li, Ke-Hong Bi

Oncol Rep· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP.
Hai Zhou, Miao Xu, Ping Qin, Hai-yan Zhang, Cheng-lu Yuan, Ke-hong Bi

Blood· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Study of WIF-1 promoter methylation with expressions of β-catenin in acute leukemia].
Yan Wang, Chuan-sheng Zhu, Ke-hong Bi, Wen-wei Xu, Lin Dong

Zhonghua Yi Xue Za Zhi· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A preliminary study on the implication of Apaf-1 promoter methylation and the expression of apoptosis inhibitor protein Apollon in adult acute leukemia].
Jun Guo, Chuan-Sheng Zhu, Wen-Wei Xu, Yan Wang, Lin Dong, Ke-Hong Bi

Zhonghua Xue Ye Xue Za Zhi· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between cytokines and leukocytosis in patients with APL induced by all-trans retinoic acid or arsenic trioxide.
Ke Hong Bi, Guo Sheng Jiang

Cell Mol Immunol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis